Yan Ding
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
-
- Eicosanoids and Hypertension Pharmacology 5
- Co-authors
- Xin Chen (10 shared papers)Jinbao Liu (11 shared papers)Daolin Tang (9 shared papers)Øystein Fodstad (3 shared papers)Yuhua Zhao (3 shared papers)Ming Tan (3 shared papers)Ming Zhou (2 shared papers)Kangping Cui (10 shared papers)
- Journals
- Journal of Hazardous Materials (4 papers)Cell Death Discovery (3 papers)Oncology Reports (3 papers)Frontiers in Oncology (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yan Ding
139 papers receiving 3.7k citations
Yan Ding's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 474
- Biochemistry 158
- Water Science and Technology 239
- Pulmonary and Respiratory Medicine 327
- Pollution 109
Countries citing papers authored by Yan Ding
This map shows the geographic impact of Yan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ding more than expected).
Fields of papers citing papers by Yan Ding
This network shows the impact of papers produced by Yan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ding. The network helps show where Yan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Copper-dependent autophagic degradation of GPX4 drives ferroptosis Hit paper breakdown → | 2023 | 515 |
| 2 | 2010 | 366 | |
| 3 | 2009 | 225 | |
| 4 | 2021 | 190 | |
| 5 | H3K18 lactylation of senescent microglia potentiates brain aging and Alzheimer's disease through the NFκB signaling pathway Hit paper breakdown → | 2023 | 189 |
| 6 | 2013 | 121 | |
| 7 | 2012 | 94 | |
| 8 | 2019 | 91 | |
| 9 | 2020 | 90 | |
| 10 | 2023 | 66 | |
| 11 | 2015 | 62 | |
| 12 | 2012 | 61 | |
| 13 | 2005 | 57 | |
| 14 | 2023 | 54 | |
| 15 | 2013 | 52 | |
| 16 | 2022 | 49 | |
| 17 | 2021 | 48 | |
| 18 | 2019 | 45 | |
| 19 | 2014 | 44 | |
| 20 | 2024 | 43 |
About Yan Ding
Yan Ding is a scholar working on Cancer Research, Biochemistry, Epidemiology, Immunology and Molecular Biology, having authored 154 papers that have together received 3.8k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers), MicroRNA in disease regulation (5 papers), Ubiquitin and proteasome pathways (4 papers), Ferroptosis and cancer prognosis (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Advanced oxidation water treatment (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (474 citations), Biochemistry (158 citations), Water Science and Technology (239 citations), Pulmonary and Respiratory Medicine (327 citations) and Pollution (109 citations). Yan Ding has collaborated with scholars based in China, United States and France. Frequent co-authors include Xin Chen, Jinbao Liu, Daolin Tang, Øystein Fodstad, Yuhua Zhao, Ming Tan, Ming Zhou, Kangping Cui, Yihan Chen and Daniel J. Klionsky. Their work appears in journals such as Journal of Hazardous Materials, Cell Death Discovery, Oncology Reports, Frontiers in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.